Biochemical analyses demonstrated that SOD activity was markedly elevated in the GPR43-OE group (1258.00 ± 92.92 U/g) relative to AD group (718.10 ± 61.34 U/g; p < 0.05; Fig. 5B). The gene discussed is FFAR2; the disease is Alzheimer disease.